GlassScriptPhysician profile
Nikki Joseph
NPI 1174057137
$2,291.64
in general payments reported to CMS, 2019-2025
20 companies · $137 in 2025
The $137 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $166 · 2021: $633 · 2022: $705 · 2023: $345 · 2024: $305 · 2025: $137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $787.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $787.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $476.86 | 2020-2023 | Rybelsus, Ozempic |
| Stryker Corporation | $325.94 | 2022-2024 | Mako |
| Boehringer Ingelheim Pharmaceuticals, INC. | $302.71 | 2020-2023 | Jardiance |
| Amgen INC. | $276.14 | 2020-2025 | Repatha, Repatha, Otezla |
| Lilly USA, LLC | $193.24 | 2020-2024 | Zepbound, Mounjaro |
| Janssen Pharmaceuticals, INC | $164.20 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $115.86 | 2021-2023 | Farxiga |
| Glaxosmithkline, LLC. | $85.35 | 2022-2025 | Trelegy Ellipta, Arexvy |
| Novartis Pharmaceuticals Corporation | $67.08 | 2025 | |
| Exact Sciences Corporation | $50.14 | 2023 | Cologuard Collection Kit |
| Depuy Synthes Sales INC. | $40.18 | 2024 | Spotlight |
| Kowa Pharmaceuticals America, INC. | $39.99 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $38.19 | 2020-2021 | |
| Vivus LLC | $21.44 | 2023 | Pancreaze |
| Bayer Healthcare Pharmaceuticals INC. | $19.53 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.94 | 2023 | Xifaxan |
| Hologic Sales and Service, LLC | $15.77 | 2021 | |
| Pfizer INC. | $15.38 | 2022 | |
| Currax Pharmaceuticals LLC | $14.56 | 2021 | |
| Eisai INC. | $11.14 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nikki Joseph listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.